Yale Cancer Center | Strategic Alliance Partners

Yale Cancer Center (YCC) is one of only 56 National Cancer Institute-designated comprehensive cancer centers in the nation and the only such center in Connecticut. Cancer treatment for patients is available at Smilow Cancer Hospital through 13 multidisciplinary teams and at 15 Smilow Cancer Hospital Care Centers in Connecticut and Rhode Island. Comprehensive cancer centers play a vital role in the advancement of the NCI’s goal of reducing morbidity and mortality from cancer through scientific research, cancer prevention, and innovative cancer treatment.

Latest from Yale Cancer Center

Robust Sipuleucel-T Immune Activity Is Detailed in Pooled Data Analysis

October 24, 2012

Article

Patients who received sipuleucel-T developed immune parameters that correlated with improved overall survival suggesting that these parameters should be the focus of further studies on the treatment.

Dr. Herbst Explores Molecular Testing in Lung Cancer

August 15, 2012

Video

Dr. Roy S. Herbst, from Yale Cancer Center, Explores Molecular Testing in Lung Cancer

Making a Mark in Lung Cancer: An Interview With Roy S. Herbst, MD, PhD

October 04, 2011

Article

Roy S. Herbst, MD, PhD, is a physician and translational researcher, whose work in developing novel, personalized therapies for lung cancer has helped drive significant changes in the way the disease is treated.

Dr. Herbst on the 2011 Lung Cancer Congress Themes

August 10, 2011

Video

Dr. Roy S. Herbst from Yale Comprehensive Cancer Center on Themes From the 2011 Lung Cancer Congress

Dr. Herbst on the International Lung Cancer Congress

August 09, 2011

Video

Dr. Roy S. Herbst from Yale comprehensive cancer center on the International Lung Cancer Congress

Dr. Herbst on the 2011 Lung Cancer Congress Topics

August 08, 2011

Video

Dr. Roy Herbst from the Yale Comprehensive Cancer Center on Screening Studies at the Upcoming Lung Cancer Congress